With a new president, what happens to the Cancer Moonshot? And how likely is it to succeed, anyway?
Changes in epigenetics suggest a predictive marker for childhood ependymomas and similarities with DIPG tumors.
Roughly 1 in 50 promising cancer drug candidates makes it to market. What’s holding the other 49 back?
Part of the national Cancer Moonshot, a new data repository of cancer patients’ analyzed blood samples aims to stimulate translational research across industry and academia.
The tiny, scaffoldlike device facilitates early detection of metastatic cancer cells and improves survival, a new study finds.
The marriage of immune science and cancer research may improve survival rates for some individuals with rare cancers. A groundbreaking U-M scientist explains more.